Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	903	1,071	674	103	439	605
Market Cap Growth	-26.09%	58.86%	553.77%	-76.50%	-27.42%	116.90%
Enterprise Value	816	1,000	633	109	409	587
Last Close Price	13.33	17.41	12.24	2.77	14.81	23.86
PS Ratio	10503.97	-	-	147.32	309.48	-
PB Ratio	9.74	9.32	15.20	-45.87	12.30	26.41
P/TBV Ratio	10.13	9.66	16.99	-	14.78	37.28
EV/Sales Ratio	9488.58	-	-	156.14	288.38	-
Debt / Equity Ratio	0.09	0.08	0.21	-33.79	0.32	0.50
Asset Turnover	0.00	-	-	0.01	0.03	-
Quick Ratio	9.82	11.74	6.61	10.22	3.37	2.70
Current Ratio	10.02	11.88	6.76	10.39	4.30	2.95
Return on Equity (ROE)	-86.99%	-67.31%	-200.46%	-349.89%	-217.33%	-185.90%
Return on Assets (ROA)	-48.90%	-36.70%	-39.75%	-54.93%	-82.44%	-75.06%
Return on Capital (ROIC)	-52.47%	-39.67%	-42.82%	-60.15%	-97.02%	-87.10%
Return on Capital Employed (ROCE)	-79.70%	-46.00%	-83.10%	-80.80%	-137.80%	-148.20%
Earnings Yield	-8.27%	-5.00%	-6.26%	-56.73%	-14.51%	-8.24%
FCF Yield	-5.40%	-3.40%	-4.92%	-45.98%	-12.43%	-5.92%
Buyback Yield / Dilution	-15.44%	-17.41%	-46.56%	-21.35%	-20.29%	-12.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q